A new drug target in atherosclerosis: The anaphylatoxin C5a

For decades, doctors have looked at fitness levels, weight, and overall health risk factors for heart disease and stroke. Now, they may soon add a new risk factor to the list: activation of the complement system. The complement system is usually imp…

Get more stuff like this
in your inbox

From anti-aging to the search for alien life, we promise to never bore.